CD8A and neoplasm: The combination of STING activation, ICD, andimmunomodulation effectively reprograms the TME, enhances DC and CD8+ T cell activation, and suppresses tumor progression and metastasisin multiple tumor models, including immunologically cold tumors likeglioblastoma and PDAC.